DDInter1171 DDInter740
A sulfur containing essential amino acid that is important in many body functions. It is a chelating agent for heavy metals.
Flecainide is a Class I anti-arrhythmic agent like [encainide] and [propafenone]. Flecainide’s development began in 1966 and was first synthesized in 1972 as an attempt to generate new anesthetics. It is used to prevent supraventricular and ventricular arrhythmias, as well as paroxysmal atrial fibrillation and flutter.[L8878,L5056] Flecainide was granted FDA approval on 31 October 1985.
Methionine {u} (Compound) resembles {v} (Compound) L-Arginine
L-Arginine {u} (Compound) causes {v} (Side Effect) Tachycardia
Tachycardia {u} (Side Effect) is caused by {v} (Compound) Flecainide
Methionine {u} (Compound) resembles {v} (Compound) L-Alanine
L-Alanine {u} (Compound) binds {v} (Gene) AARS
AARS {u} (Gene) is upregulated by {v} (Compound) Flecainide
Methionine {u} (Compound) resembles {v} (Compound) L-Glutamine
L-Glutamine {u} (Compound) upregulates {v} (Gene) CDK6
CDK6 {u} (Gene) is upregulated by {v} (Compound) Flecainide
Methionine {u} (Compound) binds {v} (Gene) METAP2
METAP2 {u} (Gene) regulates {v} (Gene) MTHFD2
MTHFD2 {u} (Gene) is upregulated by {v} (Compound) Flecainide
Methionine {u} (Compound) resembles {v} (Compound) L-Glutamine
L-Glutamine {u} (Compound) causes {v} (Side Effect) Dizziness
Dizziness {u} (Side Effect) is caused by {v} (Compound) Flecainide
Methionine {u} (Compound) binds {v} (Gene) MTR
MTR {u} (Gene) regulates {v} (Gene) EXT1
EXT1 {u} (Gene) is downregulated by {v} (Compound) Flecainide
Methionine {u} may cause a minor interaction that can limit clinical effects when taken with {v} Mexiletine
Mexiletine {u} (Compound) binds {v} (Gene) SCN4A
SCN4A {u} (Gene) is bound by {v} (Compound) Flecainide
Methionine {u} may cause a minor interaction that can limit clinical effects when taken with {v} Mexiletine
Mexiletine {u} may cause a moderate interaction that could exacerbate diseases when taken with {v} Mefloquine
Mefloquine {u} (Compound) resembles {v} (Compound) Flecainide
Methionine {u} may cause a minor interaction that can limit clinical effects when taken with {v} Ephedrine
Ephedrine {u} (Compound) causes {v} (Side Effect) Paranoia
Paranoia {u} (Side Effect) is caused by {v} (Compound) Flecainide
Methionine (Compound) resembles L-Arginine (Compound) and L-Arginine (Compound) causes Tachycardia (Side Effect) and Tachycardia (Side Effect) is caused by Flecainide (Compound)
Methionine (Compound) resembles L-Alanine (Compound) and L-Alanine (Compound) binds AARS (Gene) and AARS (Gene) is upregulated by Flecainide (Compound)
Methionine (Compound) resembles L-Glutamine (Compound) and L-Glutamine (Compound) upregulates CDK6 (Gene) and CDK6 (Gene) is upregulated by Flecainide (Compound)
Methionine (Compound) binds METAP2 (Gene) and METAP2 (Gene) regulates MTHFD2 (Gene) and MTHFD2 (Gene) is upregulated by Flecainide (Compound)
Methionine (Compound) resembles L-Glutamine (Compound) and L-Glutamine (Compound) causes Dizziness (Side Effect) and Dizziness (Side Effect) is caused by Flecainide (Compound)
Methionine (Compound) binds MTR (Gene) and MTR (Gene) regulates EXT1 (Gene) and EXT1 (Gene) is downregulated by Flecainide (Compound)
Methionine may cause a minor interaction that can limit clinical effects when taken with Mexiletine and Mexiletine (Compound) binds SCN4A (Gene) and SCN4A (Gene) is bound by Flecainide (Compound)
Methionine may cause a minor interaction that can limit clinical effects when taken with Mexiletine and Mexiletine may cause a moderate interaction that could exacerbate diseases when taken with Mefloquine and Mefloquine (Compound) resembles Flecainide (Compound)
Methionine may cause a minor interaction that can limit clinical effects when taken with Ephedrine and Ephedrine (Compound) causes Paranoia (Side Effect) and Paranoia (Side Effect) is caused by Flecainide (Compound)